Yuntao Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuntao Ma has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
Ming Hu
The First Clinical Medical College, Gansu University of Traditional Chinese Medicine, Lanzhou, China
10 shared publicationsYuqi Ma
Department of General Surgery, Gansu Provincial Hospital, Lanzhou, China
8 shared publicationsJin Guo
Department of General Surgery and Robotic Surgery Center, Gansu Provincial Hospital, Lanzhou, China
6 shared publicationsMingze Zhang
Lanzhou University Second Clinical School of Medicine, Lanzhou, China
6 shared publicationsGuoyuan Yang
Linxia State Hospital, Linxia, China
5 shared publicationsWeipeng Zhan
Department of General Surgery, Gansu Provincial Hospital, Lanzhou, China
5 shared publications
Latest Publications
- Open Access
- 24 March 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (3) , e71753
Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Current Status, Challenges, and Future Perspectives
Gastric cancer remains a leading cause of cancer‐related mortality worldwide, with locally advanced gastric/gastroesophageal junction adenocarcinoma posing significant therapeutic challenges. Neoadjuvant therapy has emerged as a critical strategy to improve surgical outcomes and long‐term survival by reducing tumor burden and eradicating micrometastases. This systematic review integrates evidence from more than 100 clinical trials and 20 meta‐analyses published in recent years. It focuses on new advances in neoadjuvant therapies for gastric cancer, including chemotherapy, radiotherapy, immunotherapy, and targeted therapies, while highlighting emerging combination strategies and unresolved clinical dilemmas.
- 24 March 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (3) , e71753
Open AccessNeoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Current Status, Challenges, and Future Perspectives
Gastric cancer remains a leading cause of cancer‐related mortality worldwide, with locally advanced gastric/gastroesophageal junction adenocarcinoma posing significant therapeutic challenges. Neoadjuvant therapy has emerged as a critical strategy to improve surgical outcomes and long‐term survival by reducing tumor burden and eradicating micrometastases. This systematic review integrates evidence from more than 100 clinical trials and 20 meta‐analyses published in recent years. It focuses on new advances in neoadjuvant therapies for gastric cancer, including chemotherapy, radiotherapy, immunotherapy, and targeted therapies, while highlighting emerging combination strategies and unresolved clinical dilemmas.
- Open Access
- 11 March 2026
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 24 (1)
A comparative study of the ‘3 + 2’ model ‘seven-step method’ programmed robotic distal gastric cancer radical resection versus conventional robotic surgical techniques
- 11 March 2026
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 24 (1)
Open AccessA comparative study of the ‘3 + 2’ model ‘seven-step method’ programmed robotic distal gastric cancer radical resection versus conventional robotic surgical techniques
- Open Access
- 14 February 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Comparative outcomes of Toumai robotic and laparoscopic transabdominal preperitoneal inguinal hernia repair in a retrospective cohort
To compare the clinical efficacy of the “Toumai” surgical robot and conventional laparoscopic inguinal hernia repair in order to inform surgical practice. A retrospective analysis was conducted on clinical data from 50 patients who underwent inguinal hernia repair at the Department of General Surgery, Gansu Provincial Hospital, between January 2022 and October 2023. Among them, 16 patients received robot-assisted repair (robotic group), and 34 underwent conventional laparoscopic repair (laparoscopic group), all via the transabdominal preperitoneal approach. Evaluation indicators included: (1) preoperative baseline characteristics; (2) intraoperative and postoperative outcomes; and (3) postoperative incision healing and adverse events. Outpatient follow-up and clinical re-examination were conducted 1 to 3 months after surgery to assess wound recovery and recurrence. Continuous variables were expressed as mean ± standard deviation or median (M), and analyzed using the t-test; categorical data were compared using the chi-square test. There were no significant differences in baseline characteristics between the robot-assisted and laparoscopic groups, including sex ratio, age, weight, and hernia classification (P > 0.05). Intraoperatively and postoperatively, the robot group had a significantly longer operative time (104.19 ± 18.93 min vs. 90.17 ± 22.31 min), but demonstrated significantly less blood loss (6.94 ± 3.80 mL vs. 12.24 ± 9.31 mL), shorter hospital stay (3.18 ± 0.54 vs. 3.68 ± 0.81 days), lower pain scores (2.06 ± 0.93 vs. 3.03 ± 1.29), and reduced Subjective Mental Load Scale scores (18.12 ± 12.23 vs. 30.17 ± 11.46) compared to the laparoscopic group (all P < 0.05). No intraoperative complications were observed in either group. Follow-up results showed that postoperative recurrence occurred in 1 case in the robot group and 2 cases in the laparoscopic group. Poor incision healing occurred in 0 and 3 cases, and incision pain in 1 and 4 cases, respectively. In this retrospective cohort, Toumai robot-assisted repair was associated with lower estimated blood loss, lower postoperative pain scores, and shorter length of stay, but longer operative time, compared with laparoscopic repair.
- 14 February 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessComparative outcomes of Toumai robotic and laparoscopic transabdominal preperitoneal inguinal hernia repair in a retrospective cohort
To compare the clinical efficacy of the “Toumai” surgical robot and conventional laparoscopic inguinal hernia repair in order to inform surgical practice. A retrospective analysis was conducted on clinical data from 50 patients who underwent inguinal hernia repair at the Department of General Surgery, Gansu Provincial Hospital, between January 2022 and October 2023. Among them, 16 patients received robot-assisted repair (robotic group), and 34 underwent conventional laparoscopic repair (laparoscopic group), all via the transabdominal preperitoneal approach. Evaluation indicators included: (1) preoperative baseline characteristics; (2) intraoperative and postoperative outcomes; and (3) postoperative incision healing and adverse events. Outpatient follow-up and clinical re-examination were conducted 1 to 3 months after surgery to assess wound recovery and recurrence. Continuous variables were expressed as mean ± standard deviation or median (M), and analyzed using the t-test; categorical data were compared using the chi-square test. There were no significant differences in baseline characteristics between the robot-assisted and laparoscopic groups, including sex ratio, age, weight, and hernia classification (P > 0.05). Intraoperatively and postoperatively, the robot group had a significantly longer operative time (104.19 ± 18.93 min vs. 90.17 ± 22.31 min), but demonstrated significantly less blood loss (6.94 ± 3.80 mL vs. 12.24 ± 9.31 mL), shorter hospital stay (3.18 ± 0.54 vs. 3.68 ± 0.81 days), lower pain scores (2.06 ± 0.93 vs. 3.03 ± 1.29), and reduced Subjective Mental Load Scale scores (18.12 ± 12.23 vs. 30.17 ± 11.46) compared to the laparoscopic group (all P < 0.05). No intraoperative complications were observed in either group. Follow-up results showed that postoperative recurrence occurred in 1 case in the robot group and 2 cases in the laparoscopic group. Poor incision healing occurred in 0 and 3 cases, and incision pain in 1 and 4 cases, respectively. In this retrospective cohort, Toumai robot-assisted repair was associated with lower estimated blood loss, lower postoperative pain scores, and shorter length of stay, but longer operative time, compared with laparoscopic repair.
- 12 December 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (3) , 2127-2135
Clinical application and observation of 5G remote robotic radical gastrectomy for gastric cancer
Objective To evaluate the safety and short-term efficacy of 5G remote robotic surgery in radical gastrectomy for gastric cancer, with a focus on technical feasibility and perioperative outcomes. Methods A retrospective analysis was conducted on ten cases of 5G remote robotic radical gastrectomy for gastric cancer performed between May 2023 and November 2024 at Gansu Provincial Hospital in collaboration with the Affiliated Hospital of Yangzhou University and the New District Branch of Gansu Provincial Hospital. Primary endpoints included intraoperative network latency, operative duration, estimated blood loss, D2 lymphadenectomy adequacy, Clavien–Dindo complication grade, and R0 resection rate, and other indicators. Results Network Parameters: For procedures with a communication distance of 1758 km (n = 5), the median (interquartile range, IQR) network latency was 91 (70–100) ms; for those with a distance of 63 km (n = 5), the median (IQR) latency was 51 (46–71.5) ms. No obvious abnormalities in the network connection. Surgical outcomes: Total gastrectomy (n = 3) had a median of 285 min (IQR 265–320), while distal gastrectomy (n = 7) had a median of 230 min (IQR 200–260). Estimated intraoperative blood loss 35 ± 13.44 mL. One patient required 3 units RBC transfusion for preoperative anemia. Conversion to open surgery rate was 0%. Complications: All postoperative complications were ≤ Clavien–Dindo Grade II, with no severe adverse events. Pathological Results: The number of dissected lymph nodes was 32.8 ± 7.08, the number of positive lymph nodes was 2.9 ± 3.81, and the R0 resection rate was 100%. Conclusion This study preliminarily confirms that 5G remote robotic radical gastrectomy is technically feasible and has good short-term safety. Despite the limitation of a small sample size, its results provide a reference for conducting pilot studies on remote surgery. In the future, larger-scale, long-term follow-up-controlled studies will be needed to further verify its clinical value and cost-effectiveness.
- 12 December 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (3) , 2127-2135
Clinical application and observation of 5G remote robotic radical gastrectomy for gastric cancer
Objective To evaluate the safety and short-term efficacy of 5G remote robotic surgery in radical gastrectomy for gastric cancer, with a focus on technical feasibility and perioperative outcomes. Methods A retrospective analysis was conducted on ten cases of 5G remote robotic radical gastrectomy for gastric cancer performed between May 2023 and November 2024 at Gansu Provincial Hospital in collaboration with the Affiliated Hospital of Yangzhou University and the New District Branch of Gansu Provincial Hospital. Primary endpoints included intraoperative network latency, operative duration, estimated blood loss, D2 lymphadenectomy adequacy, Clavien–Dindo complication grade, and R0 resection rate, and other indicators. Results Network Parameters: For procedures with a communication distance of 1758 km (n = 5), the median (interquartile range, IQR) network latency was 91 (70–100) ms; for those with a distance of 63 km (n = 5), the median (IQR) latency was 51 (46–71.5) ms. No obvious abnormalities in the network connection. Surgical outcomes: Total gastrectomy (n = 3) had a median of 285 min (IQR 265–320), while distal gastrectomy (n = 7) had a median of 230 min (IQR 200–260). Estimated intraoperative blood loss 35 ± 13.44 mL. One patient required 3 units RBC transfusion for preoperative anemia. Conversion to open surgery rate was 0%. Complications: All postoperative complications were ≤ Clavien–Dindo Grade II, with no severe adverse events. Pathological Results: The number of dissected lymph nodes was 32.8 ± 7.08, the number of positive lymph nodes was 2.9 ± 3.81, and the R0 resection rate was 100%. Conclusion This study preliminarily confirms that 5G remote robotic radical gastrectomy is technically feasible and has good short-term safety. Despite the limitation of a small sample size, its results provide a reference for conducting pilot studies on remote surgery. In the future, larger-scale, long-term follow-up-controlled studies will be needed to further verify its clinical value and cost-effectiveness.
- Open Access
- 25 November 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16
Inflammatory factors collaboratively link Helicobacter pylori-induced gastritis to gastric cancer
Long-term inflammatory reaction may promote gastric cancer initiation and development through multiple mechanisms. Recent studies have demonstrated that inflammatory mediators play a crucial role in the transition from gastritis to gastric cancer. Pro-inflammatory cytokines, chemokines, and other signaling molecules interact and synergistically regulate gastric epithelial cell proliferation, apoptosis, migration, and invasiveness, thereby promoting tumorigenesis. Specifically, interleukins activate immune cells, induce the secretion of inflammatory mediators, and maintain local immune responses; however, in the context of cancer, they exhibit a dual role by both enhancing anti-tumor immunity and driving tumor progression. Tumor necrosis factor amplifies immune responses by stimulating the production of pro-inflammatory cytokines, yet excessive or chronic Tumor necrosis factor activity is a hallmark of autoimmune diseases. Interferons initiate antiviral responses, modulate immune cell functions, and influence the inflammatory cascade. Chemokines primarily mediate the recruitment of immune cells to sites of infection, inflammation, or injury, but also play key roles in immune evasion and tumor immune regulation. This review summarizes the cooperative roles of these inflammatory mediators in the progression from gastritis to gastric cancer and discusses their potential as therapeutic targets. A better understanding of these mechanisms may facilitate the development of novel strategies for the prevention and treatment of gastric cancer.
- 25 November 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16
Open AccessInflammatory factors collaboratively link Helicobacter pylori-induced gastritis to gastric cancer
Long-term inflammatory reaction may promote gastric cancer initiation and development through multiple mechanisms. Recent studies have demonstrated that inflammatory mediators play a crucial role in the transition from gastritis to gastric cancer. Pro-inflammatory cytokines, chemokines, and other signaling molecules interact and synergistically regulate gastric epithelial cell proliferation, apoptosis, migration, and invasiveness, thereby promoting tumorigenesis. Specifically, interleukins activate immune cells, induce the secretion of inflammatory mediators, and maintain local immune responses; however, in the context of cancer, they exhibit a dual role by both enhancing anti-tumor immunity and driving tumor progression. Tumor necrosis factor amplifies immune responses by stimulating the production of pro-inflammatory cytokines, yet excessive or chronic Tumor necrosis factor activity is a hallmark of autoimmune diseases. Interferons initiate antiviral responses, modulate immune cell functions, and influence the inflammatory cascade. Chemokines primarily mediate the recruitment of immune cells to sites of infection, inflammation, or injury, but also play key roles in immune evasion and tumor immune regulation. This review summarizes the cooperative roles of these inflammatory mediators in the progression from gastritis to gastric cancer and discusses their potential as therapeutic targets. A better understanding of these mechanisms may facilitate the development of novel strategies for the prevention and treatment of gastric cancer.
- 28 August 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (11) , 7336-7346
The safety and feasibility of telerobotic cholecystectomy via a 5G network: a prospective controlled clinical trial
Background Since advances in the fifth-generation (5G) communication technology have effectively facilitated the development of robotic telesurgery, the popularity of telerobotic operations has increased. The purpose of this study was to evaluate the safety and feasibility of robotic telecholecystectomy with a 5G wireless network using a new domestic robotic surgical system. Methods This study is a prospective controlled clinical trial. From 2023, our center conducted two independent prospective clinical trials using the Toumai® laparoscopic surgical robot. The 5G remote robotic cholecystectomy clinical trial was conducted from May to August 2023 and included a total of 20 patients in the remote group. The local robotic general surgical trial was conducted from June 2023 to October 2023 and included a total of 20 patients undergoing cholecystectomy in the local group. The surgical success rate (intraoperative and within 24 h postoperatively) was the primary endpoint, and the docking time, console time, intraoperative blood loss, complications, postoperative hospitalization days, delay time in the network, and packet loss were used as the secondary endpoints. Results The surgical success rates in the two groups were 95 and 100%. Compared with the local group, the remote group had a significantly shorter docking time (7.6 ± 2.5 vs. 9.9 ± 3.4 min, p = 0.02). No statistical differences in console time, intraoperative blood loss, and hospitalization time were observed (p > 0.05). The 5G communication network remained stable throughout all procedures, with consistent metrics for latency, jitter, and bandwidth as monitored by the technical team. The communication environment was stable, and the average network delay time was 43.4 ms, network jitter was 4 ms, the upload rate was 98.3 Mbps, the download rate was 213 Mbps, and packet loss < 1% as monitored by the clinical engineers. Conclusions Robotic telecholecystectomy based on 5G communication technology can be performed with a level of safety and efficacy comparable to that of local robotic surgery. Graphical abstract
- 28 August 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (11) , 7336-7346
The safety and feasibility of telerobotic cholecystectomy via a 5G network: a prospective controlled clinical trial
Background Since advances in the fifth-generation (5G) communication technology have effectively facilitated the development of robotic telesurgery, the popularity of telerobotic operations has increased. The purpose of this study was to evaluate the safety and feasibility of robotic telecholecystectomy with a 5G wireless network using a new domestic robotic surgical system. Methods This study is a prospective controlled clinical trial. From 2023, our center conducted two independent prospective clinical trials using the Toumai® laparoscopic surgical robot. The 5G remote robotic cholecystectomy clinical trial was conducted from May to August 2023 and included a total of 20 patients in the remote group. The local robotic general surgical trial was conducted from June 2023 to October 2023 and included a total of 20 patients undergoing cholecystectomy in the local group. The surgical success rate (intraoperative and within 24 h postoperatively) was the primary endpoint, and the docking time, console time, intraoperative blood loss, complications, postoperative hospitalization days, delay time in the network, and packet loss were used as the secondary endpoints. Results The surgical success rates in the two groups were 95 and 100%. Compared with the local group, the remote group had a significantly shorter docking time (7.6 ± 2.5 vs. 9.9 ± 3.4 min, p = 0.02). No statistical differences in console time, intraoperative blood loss, and hospitalization time were observed (p > 0.05). The 5G communication network remained stable throughout all procedures, with consistent metrics for latency, jitter, and bandwidth as monitored by the technical team. The communication environment was stable, and the average network delay time was 43.4 ms, network jitter was 4 ms, the upload rate was 98.3 Mbps, the download rate was 213 Mbps, and packet loss < 1% as monitored by the clinical engineers. Conclusions Robotic telecholecystectomy based on 5G communication technology can be performed with a level of safety and efficacy comparable to that of local robotic surgery. Graphical abstract
- Open Access
- 2 April 2025
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 23 (1) , 1-9
A pilot study on the clinical feasibility of 5G remote robot-assisted gastrectomy
Exploring the Clinical Safety and Feasibility of 5G Remote Surgery Robot-Assisted Gastrectomy. A retrospective analysis was conducted on the clinical data of two patients who underwent 5G remote surgery robot-assisted gastrectomy at the General Surgery Clinical Center of Gansu Provincial Hospital from June to September 2024. One case involved a cross-provincial remote surgery between Gansu Provincial Hospital and Yangzhou University Affiliated Hospital, located over 1700 km apart, classified as the “long-distance patient.” The other case involved a remote surgery within the province, between Gansu Provincial Hospital and the Gansu Provincial Hospital (Lanzhou New District Branch), located 70 km apart, classified as the “short-distance patient.” General data, intraoperative conditions, network status, postoperative routine information, and postoperative follow-up data were recorded and analyzed for two patients. Both patients successfully completed the surgery. The master-slave control duration for the long-distance surgery patient and the short-distance surgery patient were 259 min and 308 min, respectively; the total surgical durations were 285 min and 320 min, respectively. Neither patient experienced an intraoperative conversion to traditional surgery. The average total delay for the long-distance surgery patient was 99 ms, and for the short-distance surgery patient, it was 48 ms; the packet loss rates were 0.0188% and 0%, respectively, with no network jitter or interruptions observed. The long-distance surgery patient had a drainage tube retention time of 10 d, a postoperative hospital stay of 14 d. The short-distance surgery patient had a drainage tube retention time of 8 d, a postoperative hospital stay of 10 d. No postoperative complications occurred in either patient. This study suggests that 5G remote surgery is feasible and safe, but larger-scale research is needed.
- 2 April 2025
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 23 (1) , 1-9
Open AccessA pilot study on the clinical feasibility of 5G remote robot-assisted gastrectomy
Exploring the Clinical Safety and Feasibility of 5G Remote Surgery Robot-Assisted Gastrectomy. A retrospective analysis was conducted on the clinical data of two patients who underwent 5G remote surgery robot-assisted gastrectomy at the General Surgery Clinical Center of Gansu Provincial Hospital from June to September 2024. One case involved a cross-provincial remote surgery between Gansu Provincial Hospital and Yangzhou University Affiliated Hospital, located over 1700 km apart, classified as the “long-distance patient.” The other case involved a remote surgery within the province, between Gansu Provincial Hospital and the Gansu Provincial Hospital (Lanzhou New District Branch), located 70 km apart, classified as the “short-distance patient.” General data, intraoperative conditions, network status, postoperative routine information, and postoperative follow-up data were recorded and analyzed for two patients. Both patients successfully completed the surgery. The master-slave control duration for the long-distance surgery patient and the short-distance surgery patient were 259 min and 308 min, respectively; the total surgical durations were 285 min and 320 min, respectively. Neither patient experienced an intraoperative conversion to traditional surgery. The average total delay for the long-distance surgery patient was 99 ms, and for the short-distance surgery patient, it was 48 ms; the packet loss rates were 0.0188% and 0%, respectively, with no network jitter or interruptions observed. The long-distance surgery patient had a drainage tube retention time of 10 d, a postoperative hospital stay of 14 d. The short-distance surgery patient had a drainage tube retention time of 8 d, a postoperative hospital stay of 10 d. No postoperative complications occurred in either patient. This study suggests that 5G remote surgery is feasible and safe, but larger-scale research is needed.
- Open Access
- 4 February 2025
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 13, 1523958
Implication of protein post translational modifications in gastric cancer
Gastric cancer (GC) is one of the most common and highly lethal malignant tumors worldwide, and its occurrence and development are regulated by multiple molecular mechanisms. Post-translational modifications (PTM) common forms include ubiquitylation, phosphorylation, acetylation and methylation. Emerging research has highlighted lactylation and glycosylation. The diverse realm of PTM and PTM crosstalk is linked to many critical signaling events involved in neoplastic transformation, carcinogenesis and metastasis. This review provides a comprehensive overview of the impact of PTM on the occurrence and progression of GC. Specifically, aberrant PTM have been shown to alter the proliferation, migration, and invasion capabilities of GC cells. Moreover, PTM are closely associated with resistance to chemotherapeutic agents in GC. Notably, this review also discusses the phenomenon of PTM crosstalk, highlighting the interactions among PTM and their roles in regulating signaling pathways and protein functions. Therefore, in-depth investigation into the mechanisms of PTM and the development of targeted therapeutic strategies hold promise for advancing early diagnosis, treatment, and prognostic evaluation of GC, offering novel insights and future research directions.
- 4 February 2025
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 13, 1523958
Open AccessImplication of protein post translational modifications in gastric cancer
Gastric cancer (GC) is one of the most common and highly lethal malignant tumors worldwide, and its occurrence and development are regulated by multiple molecular mechanisms. Post-translational modifications (PTM) common forms include ubiquitylation, phosphorylation, acetylation and methylation. Emerging research has highlighted lactylation and glycosylation. The diverse realm of PTM and PTM crosstalk is linked to many critical signaling events involved in neoplastic transformation, carcinogenesis and metastasis. This review provides a comprehensive overview of the impact of PTM on the occurrence and progression of GC. Specifically, aberrant PTM have been shown to alter the proliferation, migration, and invasion capabilities of GC cells. Moreover, PTM are closely associated with resistance to chemotherapeutic agents in GC. Notably, this review also discusses the phenomenon of PTM crosstalk, highlighting the interactions among PTM and their roles in regulating signaling pathways and protein functions. Therefore, in-depth investigation into the mechanisms of PTM and the development of targeted therapeutic strategies hold promise for advancing early diagnosis, treatment, and prognostic evaluation of GC, offering novel insights and future research directions.
- 28 January 2025
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 410 (1) , 1-14
Construction and validation of a nomogram prediction model for the occurrence of complications in patients following robotic radical surgery for gastric cancer
Background In the last two decades, robotic-assisted gastrectomy has become a widely adopted surgical option for gastric cancer (GC) treatment. Despite its popularity, postoperative complications can significantly deteriorate patient quality of life and prognosis. Therefore, identifying risk factors for these complications is crucial for early detection and intervention. Objective This research is designed to construct and validate a predictive model for assessing the risk of postoperative complications in patients undergoing robotic-assisted radical gastrectomy. Methods A retrospective analysis was conducted on 500 GC patients from Gansu Provincial People’s Hospital between December 2016 and October 2023. These patients formed the training cohort. An additional 136 patients from the 940th Hospital of Joint Logistic Support Force, the Chinese People’s Liberation Army as the external validation cohort. Patients were categorized into groups with and without complications. Data collected included demographic details, laboratory results, CT quantitative body composition analysis, and clinical information. Variable selection was conducted through Lasso regression, succeeded by multivariable logistic regression to pinpoint independent risk factors. These elements facilitated the construction of a nomogram for prediction. The model’s performance underwent internal validation via bootstrap techniques and external validation through a validation cohort. The efficacy of the model was quantified by the area under the receiver operating characteristic (ROC) curve (AUC), evaluated for calibration using calibration curves and the Hosmer-Lemeshow test, and assessed for clinical utility through decision curve analysis (DCA). Results Of the 500 patients in the training cohort, 65 experienced complications, a rate of 13%. The validation cohort had a similar complication rate of 13.24% (18 out of 136 patients). Independent risk factors identified included tumor diameter (OR = 1.99, 95% CI = 1.07–3.73), TNM stage III (OR = 2.12, 95% CI = 1.03–4.36), ASA class I (OR = 0.26, 95% CI = 0.13–0.53), ASA class III (OR = 4.75, 95% CI = 2.12–10.62), and visceral fat area (VFA) (OR = 2.52, 95% CI = 1.10–5.79). The nomogram demonstrated good discrimination (AUC = 0.81, 95% CI: 0.76–0.87) in internal validation and (AUC = 0.79, 95% CI: 0.67–0.90) in external validation. Both validations confirmed the model’s accurate calibration and significant clinical utility, with net benefits observed at probability thresholds ranging from 2 to 79% and 2–71%. Conclusion The developed nomogram, based on five independent risk factors—tumor diameter, TNM stage III, ASA class I, ASA class III, and VFA—effectively predicts the risk of complications in patients undergoing robotic-assisted radical gastrectomy, offering a valuable tool for clinical decision-making.
- 28 January 2025
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 410 (1) , 1-14
Construction and validation of a nomogram prediction model for the occurrence of complications in patients following robotic radical surgery for gastric cancer
Background In the last two decades, robotic-assisted gastrectomy has become a widely adopted surgical option for gastric cancer (GC) treatment. Despite its popularity, postoperative complications can significantly deteriorate patient quality of life and prognosis. Therefore, identifying risk factors for these complications is crucial for early detection and intervention. Objective This research is designed to construct and validate a predictive model for assessing the risk of postoperative complications in patients undergoing robotic-assisted radical gastrectomy. Methods A retrospective analysis was conducted on 500 GC patients from Gansu Provincial People’s Hospital between December 2016 and October 2023. These patients formed the training cohort. An additional 136 patients from the 940th Hospital of Joint Logistic Support Force, the Chinese People’s Liberation Army as the external validation cohort. Patients were categorized into groups with and without complications. Data collected included demographic details, laboratory results, CT quantitative body composition analysis, and clinical information. Variable selection was conducted through Lasso regression, succeeded by multivariable logistic regression to pinpoint independent risk factors. These elements facilitated the construction of a nomogram for prediction. The model’s performance underwent internal validation via bootstrap techniques and external validation through a validation cohort. The efficacy of the model was quantified by the area under the receiver operating characteristic (ROC) curve (AUC), evaluated for calibration using calibration curves and the Hosmer-Lemeshow test, and assessed for clinical utility through decision curve analysis (DCA). Results Of the 500 patients in the training cohort, 65 experienced complications, a rate of 13%. The validation cohort had a similar complication rate of 13.24% (18 out of 136 patients). Independent risk factors identified included tumor diameter (OR = 1.99, 95% CI = 1.07–3.73), TNM stage III (OR = 2.12, 95% CI = 1.03–4.36), ASA class I (OR = 0.26, 95% CI = 0.13–0.53), ASA class III (OR = 4.75, 95% CI = 2.12–10.62), and visceral fat area (VFA) (OR = 2.52, 95% CI = 1.10–5.79). The nomogram demonstrated good discrimination (AUC = 0.81, 95% CI: 0.76–0.87) in internal validation and (AUC = 0.79, 95% CI: 0.67–0.90) in external validation. Both validations confirmed the model’s accurate calibration and significant clinical utility, with net benefits observed at probability thresholds ranging from 2 to 79% and 2–71%. Conclusion The developed nomogram, based on five independent risk factors—tumor diameter, TNM stage III, ASA class I, ASA class III, and VFA—effectively predicts the risk of complications in patients undergoing robotic-assisted radical gastrectomy, offering a valuable tool for clinical decision-making.